These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21115471)

  • 1. Impact of pharmacist intervention on clinical outcomes in the palliative care setting.
    Wilson S; Wahler R; Brown J; Doloresco F; Monte SV
    Am J Hosp Palliat Care; 2011 Aug; 28(5):316-20. PubMed ID: 21115471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
    Lobas NH; Lepinski PW; Abramowitz PW
    Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists' interventions.
    Bedouch P; Tessier A; Baudrant M; Labarere J; Foroni L; Calop J; Bosson JL; Allenet B
    J Eval Clin Pract; 2012 Aug; 18(4):911-8. PubMed ID: 21689216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project.
    Pottie K; Haydt S; Farrell B; Kennie N; Sellors C; Martin C; Dolovich L;
    Res Social Adm Pharm; 2009 Dec; 5(4):319-26. PubMed ID: 19962675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of pharmacists' suggestions by prescribers: a literature review.
    Klopfer JD; Einarson TR
    Hosp Pharm; 1990 Sep; 25(9):830-2, 834-6. PubMed ID: 10106942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of the presence of pharmacists in a clinical department of a Lebanese hospital.
    Rabbaa-Khabbaz L; Karam L; Farhat C; Azzi R; Karam Sarkis D
    Ann Pharm Fr; 2012 Nov; 70(6):353-9. PubMed ID: 23177562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of risk management and risk assessment information: the role of the pharmacist.
    Schommer JC; Pedersen CA; Worley MM; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL; Chewning BA
    Res Social Adm Pharm; 2006 Dec; 2(4):458-78. PubMed ID: 17161806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of a primary healthcare pharmacist.
    Kolodziejak L; Rémillard A; Neubauer S
    J Interprof Care; 2010 May; 24(3):274-84. PubMed ID: 20388026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a standardized pharmacist assessment and evaluating the role of a pharmacist in a multidisciplinary supportive oncology clinic.
    Mancini R
    J Support Oncol; 2012; 10(3):99-106. PubMed ID: 22266155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist's role in an interdisciplinary cardiac rehabilitation team.
    Packard K; Herink M; Kuhlman P
    J Allied Health; 2012; 41(3):113-7, 117a, 117b. PubMed ID: 22968772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing resident physician use of clinical pharmacy services.
    Lounsbery JL; Moon J; Humphrey A; Prasad S
    Fam Med; 2013 Jan; 45(1):33-6. PubMed ID: 23334965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of pharmacist recommendations in an aged care facility.
    Khalil H
    Aust J Prim Health; 2011; 17(1):35-9. PubMed ID: 21616022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical pharmacist interventions in reducing paediatric prescribing errors.
    Fernández-Llamazares CM; Calleja-Hernandez MA; Manrique-Rodriguez S; Pérez-Sanz C; Duran-García E; Sanjurjo-Saez M
    Arch Dis Child; 2012 Jun; 97(6):564-8. PubMed ID: 22362718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance.
    Mann A; Esse T; Abughosh SM; Serna O
    J Manag Care Spec Pharm; 2016 Jan; 22(1):49-55. PubMed ID: 27015051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.